SeekingAlpha.com: All News Financial writer reports Celularity (CELU) receives notice from Nasdaq due to delayed Form 10-Q filings, risking compliance with listing requirements.\n more…
Ticker Report Vanguard Group Inc. lowered its position in Celularity Inc. (NASDAQ:CELU - Free Report) by 89.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities...\n more…
Zolmax Dynavax Technologies (NASDAQ:DVAX - Get Free Report) and Celularity (NASDAQ:CELU - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two...\n more…
TipRanks Financial Blog Celularity (CELU) has shared an update. Marc Mazur, a key board member of Celularity, has announced his resignation, effective July 31, 2024. His departure is not t...\n more…